More than shots in the dark: improving patient stratification to move closer to personalised therapies in intrahepatic cholangiocarcinoma
Gut
.
2024 Feb 23;73(3):389-390.
doi: 10.1136/gutjnl-2023-331119.
Authors
Maria Arechederra
1
2
3
,
Andrea Casadei Gardini
4
5
,
Chiara Raggi
6
Affiliations
1
Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain.
2
CIBERehd, Instituto de Salud Carlos III, Madrid, Spain.
3
Instituto de Investigaciones Sanitarias de Navarra IdiSNA, Pamplona, Spain.
4
Medical Oncology Department, IRCSS San Raffaele Scientific Institute, Milan, Italy.
5
Department of Oncology, Vita-Salute San Raffaele University, Milan, Italy.
6
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy chiara.raggi@unifi.it.
PMID:
37890989
DOI:
10.1136/gutjnl-2023-331119
No abstract available
Keywords:
CHEMOTHERAPY; CHOLANGIOCARCINOMA.
MeSH terms
Bile Duct Neoplasms* / pathology
Bile Duct Neoplasms* / therapy
Bile Ducts, Intrahepatic / pathology
Cholangiocarcinoma* / pathology
Cholangiocarcinoma* / therapy
Humans